 Connection
Spyridoula Maraka to Hypoglycemic Agents
This is a "connection" page, showing publications Spyridoula Maraka has written about Hypoglycemic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.737 |
|
|
|
-
Maraka S, Morey-Vargas OL, Montori VM. Should we use intensive hypoglycemic treatment in patients with advanced type 2 diabetes? Pol Arch Med Wewn. 2014; 124(12):657-8.
Score: 0.435
-
O'Keeffe DT, Maraka S. Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy. Ann Intern Med. 2018 10 02; 169(7):510-511.
Score: 0.142
-
Gonz?lez-Saldivar G, Millan-Alanis JM, Gonz?lez-Gonz?lez JG, S?nchez-G?mez RA, Obeso-Fern?ndez J, McCoy RG, Maraka S, Brito JP, Ospina NS, Oyervides-Fuentes S, Rodr?guez-Guti?rrez R. Treatment burden and perceptions of glucose-lowering therapy among people living with diabetes. Prim Care Diabetes. 2022 08; 16(4):568-573.
Score: 0.046
-
Gerardo Gonz?lez-Gonz?lez J, Cesar Solis R, D?az Gonz?lez-Colmenero A, Raygoza-Cortez K, Moreno-Pe?a PJ, S?nchez AL, McCoy RG, Singh Ospina N, Maraka S, Brito JP, Rodriguez-Gutierrez R. Effect of metformin on microvascular outcomes in patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2022 Apr; 186:109821.
Score: 0.045
-
Rodriguez-Gutierrez R, Salcido-Montenegro A, Singh-Ospina NM, Maraka S, I?iguez-Ariza N, Spencer-Bonilla G, Tamhane SU, Lipska KJ, Montori VM, McCoy RG. Documentation of hypoglycemia assessment among adults with diabetes during clinical encounters in primary care and endocrinology practices. Endocrine. 2020 03; 67(3):552-560.
Score: 0.039
-
O'Keeffe DT, Maraka S, Rizza RA. HbA1c in the Evaluation of Diabetes Mellitus. JAMA. 2016 Feb 09; 315(6):605-6.
Score: 0.030
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|